Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001694187-19-000026
Filing Date
2019-03-11
Accepted
2019-03-11 17:23:15
Documents
111
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ntgn-201810xk.htm 10-K 2116108
2 EXHIBIT 10.9 exhibit109.htm EX-10.9 349405
3 EXHIBIT 10.10 exhibit1010.htm EX-10.10 21911
4 EXHIBIT 21.1 exhibit211.htm EX-21.1 3586
5 EXHIBIT 23.1 exhibit231.htm EX-23.1 2646
6 EXHIBIT 31.1 exhibit311.htm EX-31.1 14271
7 EXHIBIT 31.2 exhibit312.htm EX-31.2 14480
8 EXHIBIT 32.1 exhibit321.htm EX-32.1 9904
15 GRAPHIC bladder-tumorburdenchange.jpg GRAPHIC 92011
16 GRAPHIC cd8-tumortargets.jpg GRAPHIC 124776
17 GRAPHIC cd8andcd4inductiongraphic.jpg GRAPHIC 217148
18 GRAPHIC clinicaldevelopmentstrategy.jpg GRAPHIC 178603
19 GRAPHIC clinicaldevstrategy.jpg GRAPHIC 180431
20 GRAPHIC clinicalresults.jpg GRAPHIC 39910
21 GRAPHIC datasourcesforneoantigen-mhc.jpg GRAPHIC 79348
22 GRAPHIC epiptopespreading01.jpg GRAPHIC 77162
23 GRAPHIC histologicchanges01.jpg GRAPHIC 134668
24 GRAPHIC melanoma-tumorburdenchange.jpg GRAPHIC 127587
25 GRAPHIC neo-ptcprocess.jpg GRAPHIC 102583
26 GRAPHIC neoantigenimmunogenicitya.jpg GRAPHIC 95141
27 GRAPHIC neon10kbusinesssecti_image14.gif GRAPHIC 33084
28 GRAPHIC neon10kbusinesssecti_image15.gif GRAPHIC 35335
29 GRAPHIC neon10kbusinesssectio_image7.jpg GRAPHIC 44352
30 GRAPHIC neon-selectprocess.jpg GRAPHIC 65331
31 GRAPHIC neostimresponses.jpg GRAPHIC 89930
32 GRAPHIC neostimtcells-functional.jpg GRAPHIC 145834
33 GRAPHIC nsclc-tumorburdenchange.jpg GRAPHIC 105099
34 GRAPHIC nt001-patientdemographics.jpg GRAPHIC 73374
35 GRAPHIC nt001-safety.jpg GRAPHIC 108105
36 GRAPHIC personalmedicineapproach.jpg GRAPHIC 65247
37 GRAPHIC platform-treatmentapproaches.jpg GRAPHIC 108207
38 GRAPHIC pv01latestagewithnivo.jpg GRAPHIC 47690
39 GRAPHIC recon-overview.jpg GRAPHIC 127515
40 GRAPHIC rictorneoantigent-patientm1.jpg GRAPHIC 148144
41 GRAPHIC vaccineinducedimunity.jpg GRAPHIC 112333
  Complete submission text file 0001694187-19-000026.txt   12292356

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ntgn-20181231.xml EX-101.INS 1469473
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ntgn-20181231.xsd EX-101.SCH 59667
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ntgn-20181231_cal.xml EX-101.CAL 81219
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ntgn-20181231_def.xml EX-101.DEF 350577
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ntgn-20181231_lab.xml EX-101.LAB 783117
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ntgn-20181231_pre.xml EX-101.PRE 490237
Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Filer) CIK: 0001694187 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38551 | Film No.: 19673170
SIC: 2836 Biological Products, (No Diagnostic Substances)